PANoptosis-based molecular clustering and prognostic signature predicts patient survival and immune landscape in colon cancer.
Front Genet. 2022 Sep 14;13:955355. doi: 10.3389/fgene.2022.955355. eCollection 2022.
Front Genet. 2022.
PMID: 36186438
Free PMC article.